Drugs / GRT0151Y
last change Oct 2007 re-read 2 minutes ago

GRT0151Y

Investigated by
Grünenthal GmbH

Trials 3 · a red edge is where a trial was stopped

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03768024 Jun → Oct 2007 Grünenthal GmbH Completed No outcome recorded
Phase 1 NCT03765658 Jan → Mar 2006 chronic pain syndrome Grünenthal GmbH Completed No outcome recorded
Phase 1 NCT03761407 Dec 2004 → Jul 2005 Grünenthal GmbH Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as GRT0151Y ClinicalTrials.gov intervention name — accepted as the source's own label NCT03761407
2

NCT03765658

NCT03768024

Route Oral “Multiple Escalating Oral Doses of GRT0151Y” NCT03761407